Diabetes-associated morbidity and mortality is predominantly due to complications of the
disease that may cause debilitating conditions, such as heart and renal failure, hepatic …

Macrophages and lymphocytes demonstrate metabolic plasticity, which is dependent partly
on their state of activation and partly on the availability of various energy yielding and …

Frequencies of circulating immune cells are altered in those with type 1 and type 2 diabetes
compared with healthy individuals and are associated with insulin sensitivity, glycemic …

Nonalcoholic fatty liver disease (NAFLD) is a worldwide leading cause of chronic liver
disease, but we still lack ideal non-invasive tools for diagnosis and evaluation of …

Aldehyde dehydrogenase 2 (ALDH2) is an enzyme found in the mitochondrial matrix that
plays a central role in alcohol and aldehyde metabolism. A common ALDH2 polymorphism …

The increasing prevalence of non-alcoholic fatty liver disease (NAFLD), as well as its
advanced stage non-alcoholic steatohepatitis (NASH) with the progression of liver …

In the Western society, non-alcoholic fatty liver disease (NAFLD), characterized by the
excessive accumulation of fat in the liver, represents the most common cause of chronic liver …

Background: A systemic review of the survival benefit of immune checkpoint inhibitors (ICIs)
in phase III hepatocellular carcinoma (HCC) trials was conducted. Methods: Meta-analyses …

Nonalcoholic fatty liver disease (NAFLD) includes a series of hepatic manifestations, starting
with liver steatosis and potentially evolving towards nonalcoholic steatohepatitis (NASH) …

Background Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and …